Valutazione di efficacia di un antiangiogenetico (Bevacizumab)
Valutazione di efficacia di un antiangiogenetico (Bevacizumab)
Valutazione di efficacia di un antiangiogenetico (Bevacizumab)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BIBLIOGRAFIA<br />
[1] Tycznsky JE, Bray F, Parkin DM. Breast cancer in europe. International Agency for Research on Cancer:<br />
European Network of Cancer Registries Cancer Fact Sheet 2002; 2<br />
[2] Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, Allemani C, Ciccolallo L, Santaquilani<br />
M, Berrino F; EUROCARE Working Group. EUROCARE –3 summary: Cancer survival in Europe at the end<br />
of the 20 th century. Ann Oncol 2005; 14:128-49<br />
[3] Greena FL, Balch CM, Page DL, et al. American Joint Committee on Cancer, e<strong>di</strong>tors. AJJC Cancer<br />
Staging Manual. 6 th ed. Chicago, IL: Springer- Verlag New York Inc; 2002<br />
[4] Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev<br />
Cancer.2003;3:453-8.<br />
[5] Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor.<br />
Science.1977;197:893-5.<br />
[6] Engel J, Eckel R, Kerr J, Schmidt M, Furstenberger G, Richter R, Sauer H, Senn HJ, Holzel D.<br />
The process of metastasisation for breast cancer. Eur J Cancer. 2003;39:1794-806.<br />
[7] Bra<strong>un</strong> S, Pantel K, Muller P, Janni W, Hepp F, Kentenich CR, Gastroph S, Wischnik A, Dimpfl T,<br />
Kindermann G, Riethmuller G, Schlimok G. Cytokeratin-positive cells in the bone marrow and survival of<br />
patients with stage I, II, or III breast cancer. N Engl J Med. 2000;342:525-33.<br />
[8] Gebauer G, Fehm T, Merkle E, Beck EP, Lang N, Jager W. Epithelial cells in bone marrow of breast<br />
cancer patients at time of primary surgery: clinical outcome during long-term follow-up. J Clin Oncol.<br />
2001;19:3669-74.<br />
[9] Gerber B, Krause A, Muller H, Richter D, Reimer T, Makovitzky J, Herrnring C, Jeschke U, K<strong>un</strong>dt G,<br />
Friese K. Simultaneous imm<strong>un</strong>ohistochemical detection of tumor cells in lymph nodes and bone marrow<br />
aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol. 2001;19:960-71.<br />
[10] Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu<br />
J, Harbitz T, Naume B. Detection of isolated tumor cells in bone marrow is an independent prognostic factor<br />
in breast cancer. J Clin Oncol. 2003;21:3469-78.<br />
Maria Pittalis<br />
<strong>Valutazione</strong> <strong>di</strong> <strong>efficacia</strong> <strong>di</strong> <strong>un</strong> <strong>antiangiogenetico</strong> (<strong>Bevacizumab</strong>) associata a chemioterapia in pazienti con carcinoma<br />
della mammella metastatico<br />
Tesi <strong>di</strong> dottorato in scienze Biome<strong>di</strong>che-Epidemiologia molecolare dei tumori<br />
Università degli Stu<strong>di</strong> <strong>di</strong> Sassari<br />
80
Change language